Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2026-04-26 @ 10:13 PM
Study NCT ID:
NCT04740203
Status:
UNKNOWN
Last Update Posted:
2021-02-05
First Post:
2021-01-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph- B-ALL
Sponsor:
Organization:
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Time Perspective List:
Who Masked List: